J. Stern & Co. LLP lifted its stake in Xylem Inc. (NYSE:XYL – Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 304,326 shares of the industrial products company’s stock after acquiring an additional 14,342 shares during the period. Xylem accounts for 4.4% of J. Stern & Co. LLP’s portfolio, making the stock its 11th largest position. J. Stern & Co. LLP’s holdings in Xylem were worth $41,093,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently made changes to their positions in the stock. California State Teachers Retirement System lifted its position in shares of Xylem by 1.4% during the first quarter. California State Teachers Retirement System now owns 393,856 shares of the industrial products company’s stock valued at $50,902,000 after buying an additional 5,477 shares during the last quarter. Cetera Investment Advisers boosted its stake in Xylem by 191.7% in the first quarter. Cetera Investment Advisers now owns 27,412 shares of the industrial products company’s stock valued at $3,543,000 after acquiring an additional 18,014 shares in the last quarter. Victory Capital Management Inc. grew its holdings in Xylem by 9.3% in the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company’s stock worth $219,731,000 after purchasing an additional 137,883 shares during the last quarter. Quintet Private Bank Europe S.A. lifted its holdings in shares of Xylem by 28.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 203,262 shares of the industrial products company’s stock valued at $27,446,000 after purchasing an additional 44,414 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its position in shares of Xylem by 12.4% in the 2nd quarter. Daiwa Securities Group Inc. now owns 78,365 shares of the industrial products company’s stock worth $10,629,000 after purchasing an additional 8,664 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
Xylem Stock Down 1.6 %
Shares of NYSE:XYL traded down $2.10 on Tuesday, hitting $126.48. 68,801 shares of the company’s stock were exchanged, compared to its average volume of 1,226,727. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. Xylem Inc. has a 1-year low of $102.42 and a 1-year high of $146.08. The firm’s 50-day moving average is $130.06 and its 200 day moving average is $134.13. The company has a market capitalization of $30.73 billion, a PE ratio of 37.70, a P/E/G ratio of 2.34 and a beta of 1.05.
Xylem Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be given a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 annualized dividend and a yield of 1.14%. Xylem’s dividend payout ratio (DPR) is 42.11%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Robert W. Baird decreased their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Stifel Nicolaus increased their price objective on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Royal Bank of Canada cut their price target on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. TD Cowen cut their target price on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research report on Wednesday, November 6th. Finally, UBS Group assumed coverage on Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 target price on the stock. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and an average target price of $149.64.
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- 3 Warren Buffett Stocks to Buy Now
- 3 Stocks That Authorized $1 Billion Stock Buybacks to Boost Value
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Pure Storage’s GenAI Pods and AI Trends Could Spark Recovery
- Stock Market Sectors: What Are They and How Many Are There?
- Is Seaboard Corporation a Thanksgiving Feast for Investors?
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.